AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|AAPL308.91-24.52 (-7.35%) ▼|ABBV250.94-6.47 (-2.51%) ▼|ABT105.70+0.09 (+0.09%) ▲|ACN165.92+2.63 (+1.61%) ▲|ADBE250.41+2.51 (+1.01%) ▲|AMAT507.67+5.90 (+1.18%) ▲|AMD476.15-9.24 (-1.90%) ▼|AMGN385.16-2.48 (-0.64%) ▼|AMT173.36-1.10 (-0.63%) ▼|AMZN271.58+36.08 (+15.32%) ▲|AVGO389.28+1.44 (+0.37%) ▲|AXP336.25-1.27 (-0.38%) ▼|BA216.14-4.76 (-2.15%) ▼|BAC61.95+0.22 (+0.36%) ▲|BKNG192.90-0.34 (-0.18%) ▼|BLK1,090.39-7.98 (-0.73%) ▼|BMY65.31+0.45 (+0.69%) ▲|BNY156.33+0.25 (+0.16%) ▲|BRK-B511.54+1.86 (+0.36%) ▲|C132.45+0.13 (+0.10%) ▲|CAT814.81+5.67 (+0.70%) ▲|CL91.30-0.30 (-0.33%) ▼|CMCSA23.96+0.29 (+1.23%) ▲|COF209.01-1.13 (-0.54%) ▼|COP120.48+1.45 (+1.22%) ▲|COST951.89-2.28 (-0.24%) ▼|CRM184.02+3.31 (+1.83%) ▲|CSCO115.99+2.43 (+2.14%) ▲|CVS104.43-0.79 (-0.75%) ▼|CVX196.83+4.52 (+2.35%) ▲|DE592.67-6.80 (-1.13%) ▼|DHR194.98-1.19 (-0.61%) ▼|DIS96.19+0.03 (+0.03%) ▲|DUK125.43-0.84 (-0.67%) ▼|EMR149.82+1.18 (+0.79%) ▲|FDX307.40-1.15 (-0.37%) ▼|GD383.42+1.22 (+0.32%) ▲|GE360.07+5.03 (+1.42%) ▲|GEV990.29+8.31 (+0.85%) ▲|GILD130.21-1.07 (-0.82%) ▼|GM88.86+0.46 (+0.52%) ▲|GOOG356.65+22.97 (+6.88%) ▲|GOOGL356.13+22.47 (+6.73%) ▲|GS1,018.38-6.48 (-0.63%) ▼|HD331.96-1.39 (-0.42%) ▼|HON243.05+1.14 (+0.47%) ▲|IBM223.65+1.91 (+0.86%) ▲|INTC90.20-0.93 (-1.02%) ▼|INTU316.07+0.57 (+0.18%) ▲|ISRG353.33+0.36 (+0.10%) ▲|JNJ256.35+0.53 (+0.21%) ▲|JPM351.79+0.94 (+0.27%) ▲|KO87.59-0.90 (-1.02%) ▼|LIN478.38-30.26 (-5.95%) ▼|LLY1,148.84-6.13 (-0.53%) ▼|LMT582.74+8.63 (+1.50%) ▲|LOW207.81-2.27 (-1.08%) ▼|LRCX293.02-4.70 (-1.58%) ▼|MA573.10-4.25 (-0.74%) ▼|MCD270.64+2.20 (+0.82%) ▲|MDLZ62.31-0.77 (-1.22%) ▼|MDT85.39-0.32 (-0.37%) ▼|META556.71+17.68 (+3.28%) ▲|MMM176.28+0.21 (+0.12%) ▲|MO68.33+0.39 (+0.57%) ▲|MRK130.20+0.41 (+0.32%) ▲|MS210.42+1.51 (+0.72%) ▲|MSFT464.72+13.62 (+3.02%) ▲|MU823.03-51.63 (-5.90%) ▼|NEE86.92-1.01 (-1.15%) ▼|NFLX71.71-1.46 (-2.00%) ▼|NKE41.71-0.58 (-1.37%) ▼|NOW111.23+1.16 (+1.05%) ▲|NVDA200.75+5.71 (+2.93%) ▲|ORCL129.87+2.31 (+1.81%) ▲|PEP139.56-0.64 (-0.46%) ▼|PFE25.01+0.10 (+0.40%) ▲|PG144.49+0.53 (+0.37%) ▲|PLTR123.06+0.80 (+0.65%) ▲|PM190.82-1.18 (-0.61%) ▼|QCOM147.61-3.99 (-2.63%) ▼|RTX215.22+0.84 (+0.39%) ▲|SBUX105.25-0.60 (-0.57%) ▼|SCHW105.24+0.91 (+0.87%) ▲|SO94.54+0.20 (+0.21%) ▲|SPG229.37-1.07 (-0.46%) ▼|T23.25+0.04 (+0.17%) ▲|TMO574.30-2.47 (-0.43%) ▼|TMUS172.71-0.63 (-0.36%) ▼|TSLA311.21+2.36 (+0.76%) ▲|TXN275.74-3.02 (-1.08%) ▼|UBER70.36-0.01 (-0.01%) ▼|UNH414.40-7.07 (-1.68%) ▼|UNP292.13+2.67 (+0.92%) ▲|UPS104.22-1.05 (-1.00%) ▼|USB63.01+0.11 (+0.17%) ▲|V366.13-0.14 (-0.04%) ▼|VZ46.81+0.70 (+1.52%) ▲|WFC86.45+1.02 (+1.19%) ▲|WMT111.20+0.10 (+0.09%) ▲|XOM155.44-1.53 (-0.97%) ▼|
25 C
New York
Saturday, August 1, 2026

Tag: APRIL

newssourceFORcompanyinformationcontent1releasesmarket

Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis

BEERSE, BELGIUM, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional insight into the use of IMAAVY®▼(nipocalimab) throughout clinically relevant points in the generalised myasthenia gravis (gMG) treatment journey. The analyses include adults with anti-AChRa or anti-MuSKb antibody-positive gMG who were early in their disease course or had lower baseline symptom burden – providing insight into the potential importance of addressing pathogenic immunoglobulin G (IgG) early in disease progression where use of advanced therapies may be less common.1,2 Additional research to be shared include outcomes shortly after common infections, which are a known cause of disease exacerbations in gMG, and plans to address evidence gaps in the use of nipocalimab during pregnancy.3,4

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

New analyses from the Phase 3 Vivacity-MG3 study support the impact of IMAAVY in anti-AChR+a, anti-MuSK+b adult patients with generalized myasthenia gravis (gMG) including...

Board decision to file for bankruptcy

Ghent, June 26, 2026 (GLOBE NEWSWIRE) -- PRESS RELEASE | REGULATED INFORMATION - INSIDE INFORMATION
26 June 2026, 05:15 pm CEST

T7X Announces Infrastructure Platform for Compliant On-Chain Securities Issuance and Transfer Agent Services

Company outlines its compliance-first framework for tokenized securities as the U.S. regulatory environment for digital assets continues to evolve.

Seaspan Releases 2025 Sustainability Report, Highlighting Continued Progress on Decarbonization, Safety and Governance

SINGAPORE, June 26, 2026 /PRNewswire/ -- Seaspan Corporation Pte. Ltd. (Seaspan), leading independent maritime asset owner and operator, is pleased to announce the release...

Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes

NEW YORK, June 25, 2026 Nuvation Bio Inc. ("Nuvation Bio") (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges...

XLSMART and Tencent Cloud Successfully Complete Large-Scale AI-Driven Cloud Transformation Project

JAKARTA, Indonesia, June 26, 2026 /PRNewswire/ -- Tencent Cloud, the cloud business of global technology company Tencent, has successfully assisted leading Indonesian telecom operator...

ROSEN, A LEADING LAW FIRM, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Roblox Corporation (NYSE: RBLX) between October 30, 2025 and April 30, 2026, inclusive (the “Class Period”), of the important August 7, 2026 lead plaintiff deadline.

i-80 Gold Announces Additional High-Grade Assay Results From Archimedes Underground Including 16.2 g/t Au Over 56.4 Meters; Updates Timing of 2026 Technical Studies

TORONTO, June 25, 2026 /CNW/ - i-80 GOLD CORP. (NYSE: IAUX) (TSX: IAU) ("i-80 Gold", or the "Company") is pleased to announce the remaining assay...

i-80 Gold Announces Additional High-Grade Assay Results From Archimedes Underground Including 16.2 g/t Au Over 56.4 Meters; Updates Timing of 2026 Technical Studies

TORONTO, June 25, 2026 /PRNewswire/ - i-80 GOLD CORP. (NYSE: IAUX) (TSX: IAU) ("i-80 Gold", or the "Company") is pleased to announce the remaining assay...

BZAI Investor News: If You Have Suffered Losses in Blaize Holdings, Inc. (NASDAQ: BZAI), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Blaize Holdings, Inc. (NASDAQ: BZAI) resulting from allegations that Blaize may have issued materially misleading business information to the investing public.

American Outdoor Brands, Inc. Reports Fourth Quarter and Full Fiscal 2026 Financial Results

COLUMBIA, Mo., June 25, 2026 /PRNewswire/ -- American Outdoor Brands, Inc. (NASDAQ Global Select: AOUT), an innovation company that provides product solutions for outdoor...

Marie Brizard Wine & Spirits Description of the share buyback programme authorised by the ordinary general meeting of 25 June 2026

                                                                Charenton-le-Pont, 25 June 2026

Haffner Energy announces its estimated 2025–2026 annual results and confirms its strategic roadmap

Haffner Energy is accelerating the execution of its roadmap with CORE100, H6 and its international developments.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAPRIL

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers